DGX 8-K 5/15/15
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): May 15, 2015

 

Quest Diagnostics Incorporated
(Exact Name of Registrant as Specified in Its Charter)

 

Delaware
(State or other jurisdiction of Incorporation)

 
 
 
001-12215
 
16-1387862
(Commission File Number)

 
(I.R.S. Employer Identification No.)
 
 
 
Three Giralda Farms
Madison, NJ 07940
 
07940
(Address of principal executive offices)
 
(Zip Code)
 
 
 
(973) 520-2700
(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the exchange Act (17 CFR 240.13e-4(c))




Item 5.07 Submission of Matters to a Vote of Security Holders
 
(a)           The following is a summary of the voting results for each matter presented to the stockholders at the 2015 Annual Meeting of Stockholders of Quest Diagnostics Incorporated (the "Company").

(b)           The following nominees for the office of director were elected for terms expiring at the 2016 Annual Meeting of Stockholders, by the following votes:
 
For
 
Against
 
Abstain
 
Broker Non-Vote
 
 
 
 
 
 
 
 
Jenne K. Britell, Ph.D.
117,201,592
 
1,466,298
 
559,226
 
8,463,370
 
 
 
 
 
 
 
 
Vicky B. Gregg
116,884,298
 
1,799,049
 
543,769
 
8,463,370
 
 
 
 
 
 
 
 
Jeffrey M. Leiden, M.D., Ph.D.
116,863,568
 
1,815,910
 
547,638
 
8,463,370
 
 
 
 
 
 
 
 
Timothy L. Main
117,184,796
 
1,451,893
 
590,427
 
8,463,370
 
 
 
 
 
 
 
 
Timothy M. Ring
115,884,243
 
2,758,119
 
584,754
 
8,463,370
 
 
 
 
 
 
 
 
Daniel C. Stanzione, Ph.D.
116,246,591
 
2,354,915
 
595,610
 
8,463,370
 
 
 
 
 
 
 
 
Gail R. Wilensky, Ph.D.
115,508,217
 
3,159,007
 
559,892
 
8,463,370
 
 
 
 
 
 
 
 
John B. Ziegler
115,499,864
 
3,167,626
 
559,626
 
8,463,370
The following persons also continue as directors:
 
John C. Baldwin, M.D.
Gary M. Pfeiffer
Stephen H. Rusckowski

The advisory resolution to approve executive compensation was approved by the following votes:
For
 
Against
 
Abstain
 
Broker Non-Vote
92,081,580
 
25,539,877
 
1,605,495
 
8,463,370

The ratification of the appointment of the Company's independent registered public accounting firm for 2015 was approved by the following votes:
For
 
Against
 
Abstain
 
 
125,914,959
 
1,284,463
 
491,064
 
 
The amendments to the Company's Amended and Restated Employee Long-Term Incentive Plan were approved by the following votes:
For
 
Against
 
Abstain
 
Broker Non-Vote
102,637,560
 
16,011,199
 
578,357
 
8,463,370


2


The stockholder proposal regarding stockholders acting by written consent lieu of a meeting was not approved by the following votes:

For
 
Against
 
Abstain
 
Broker Non-Vote
58,538,233
 
59,442,317
 
1,246,394
 
8,463,370


Signature
    
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.


May 18, 2015


QUEST DIAGNOSTICS INCORPORATED



By:    /s/ William J. O'Shaughnessy, Jr.
William J. O'Shaughnessy, Jr.
Secretary


3